ECSP982736A - PIPERIDINYLAMINOMETHYL TRIFLUOROMETHYL CYCLE ETHER COMPOUNDS AS ANTAGONISTS OF THE SUBSTANCE P. - Google Patents

PIPERIDINYLAMINOMETHYL TRIFLUOROMETHYL CYCLE ETHER COMPOUNDS AS ANTAGONISTS OF THE SUBSTANCE P.

Info

Publication number
ECSP982736A
ECSP982736A ECSP982736A ECSP982736A EC SP982736 A ECSP982736 A EC SP982736A EC SP982736 A ECSP982736 A EC SP982736A EC SP982736 A ECSP982736 A EC SP982736A
Authority
EC
Ecuador
Prior art keywords
alkyl
antagonists
substance
disorders
ether compounds
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Kunio Satake
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982736 priority Critical patent/ECSP982736A/en
Publication of ECSP982736A publication Critical patent/ECSP982736A/en

Links

Landscapes

  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención proporciona un compuesto de fórmula: (gráfico), y sus sales farmacéuticamente aceptables en la que R1 es alquilo C1-C6, es hidrógeno, alquilo C1-C6, haloalquilo C1-C6 o fenilo; R3 es hidrógeno o halógeno R4 y R5 son independientemente hidrógeno, alquilo C1-C6 o haloalquilo C1-C6 y n es uno, dos o tres. Estos compuestos son útiles como análgesico o agentes anti-inflamatorios o para el tratamiento de enfermedades cardiovasculares, trastornos alérgicos, angiogénesis, trastornos del SNC, emesis, trastornos gastrointestinales, quemaduras solares, incontinencia urinaria o enfermedades trastornos y alteraciones adversas provocadas por helico-bacter pylori, o similar, en un mamifero especialmente un ser humano. También se describen intermedios para la preparación de los compuestos de fórmula (I).This invention provides a compound of formula: (graph), and its pharmaceutically acceptable salts wherein R1 is C1-C6 alkyl, is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl or phenyl; R3 is hydrogen or halogen R4 and R5 are independently hydrogen, C1-C6 alkyl or C1-C6 haloalkyl and n is one, two or three. These compounds are useful as analgesic or anti-inflammatory agents or for the treatment of cardiovascular diseases, allergic disorders, angiogenesis, CNS disorders, emesis, gastrointestinal disorders, sunburn, urinary incontinence or diseases and adverse disorders caused by helico-bacter pylori , or similar, in a mammal, especially a human being. Intermediates for the preparation of the compounds of formula (I) are also described.

ECSP982736 1998-11-11 1998-11-11 PIPERIDINYLAMINOMETHYL TRIFLUOROMETHYL CYCLE ETHER COMPOUNDS AS ANTAGONISTS OF THE SUBSTANCE P. ECSP982736A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982736 ECSP982736A (en) 1998-11-11 1998-11-11 PIPERIDINYLAMINOMETHYL TRIFLUOROMETHYL CYCLE ETHER COMPOUNDS AS ANTAGONISTS OF THE SUBSTANCE P.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982736 ECSP982736A (en) 1998-11-11 1998-11-11 PIPERIDINYLAMINOMETHYL TRIFLUOROMETHYL CYCLE ETHER COMPOUNDS AS ANTAGONISTS OF THE SUBSTANCE P.

Publications (1)

Publication Number Publication Date
ECSP982736A true ECSP982736A (en) 1999-04-16

Family

ID=42043654

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982736 ECSP982736A (en) 1998-11-11 1998-11-11 PIPERIDINYLAMINOMETHYL TRIFLUOROMETHYL CYCLE ETHER COMPOUNDS AS ANTAGONISTS OF THE SUBSTANCE P.

Country Status (1)

Country Link
EC (1) ECSP982736A (en)

Similar Documents

Publication Publication Date Title
CO4771153A1 (en) PIPERIDINYLAMINOMETHYL TRIFLUOROMETHYL CYCLE ETHER COMPOUNDS AS ANTAGONISTS OF THE SUBSTANCE P.
DOP2001000271A (en) IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS.
CR10145A (en) USEFUL TROPANAN DERIVATIVES IN THERAPY (DIVISIONAL EXP. 6800)
AR006305A1 (en) A REPLACED BENCILAMINOPIPERIDINE COMPOUND, ITS USE AND A PHARMACEUTICAL COMPOSITION CONTAINING IT
PE20030702A1 (en) PDE9 INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS
PE20030447A1 (en) DERIVATIVES N- (1,4,5,6-TETRAHIDRO-CYCLOPENTAPYRAZOL-3-IL) -SUBTITUTED AND THEIR OBTAINING
PE20020721A1 (en) QUINUCLIDINE DERIVATIVES AS ANTIMUSCARINAL AGENTS M3
UY26872A1 (en) DERIVATIVES OF THE 4- PIRIDINE PHENYL
DK1065204T3 (en) Bicyclic carbonyl indole compounds as anti-inflammatory / analgesic agents and as COX-2 inhibitors
AR048289A1 (en) ETERES OF RING IMIDAZO SULFONA REPLACED.
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
PE10897A1 (en) FUSED BENZO COMPOUNDS
AR035502A1 (en) A COMPOSITE DERIVED FROM PHENYL-REPLACED KETONE TYPE AS ANTAGONISTS OF THE PROSTAGLANDIN I2 RECEPTOR (IP), A PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND, USE OF THE SAME AND A PROCESS TO PREPARE SUCH COMPOSITE
AR029400A1 (en) DERIVATIVES OF ISOXAZOLCARBOXAMIDA, A METHOD FOR THEIR PREPARATION AND A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS
PE20020905A1 (en) DERIVATIVES OF ALCOXICARBONYLAMINOTETRAZOLIL PHENYL OR ALCOXYCARBONYLAMINE BENZOIC ACID AS IP ANTAGONISTS
ECSP982736A (en) PIPERIDINYLAMINOMETHYL TRIFLUOROMETHYL CYCLE ETHER COMPOUNDS AS ANTAGONISTS OF THE SUBSTANCE P.
AR023292A1 (en) A COMPOUND DERIVED FROM IMIDAZOL, A PROCEDURE FOR ITS PREPARATION, AND A MEDICINAL AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND
DOP2002000443A (en) PROCESS FOR QUINAZOLIN PRODUCTION
AR022797A1 (en) BENZOIL INDOLES N-SUBSTITUTED AS ESTROGEN AGENTS
UY26147A1 (en) DERIVATIVES OF 1-TRIFLUOROMETIL-4-HIDROXI-7-PIPERIDINIL-AMINOMETILCROMANO.
PE20001596A1 (en) MORPHOLIN DERIVATIVES
AR052949A1 (en) METABOLITES DERIVED FROM PIRIDINE AS NK-1 ANTAGONISTS FOR EMESIS
ES2152633T3 (en) QUINUCLIDINES REPLACED WITH TETRAZOLIL AS ANTAGONISTS OF THE SUBSTANCE P.
AR050718A1 (en) CO-CRYSTALS BETWEEN POLYETHYLENE GLYCOLSY 5-PHENYLPIRAZOLIL-1-BENCENSULPHONAMIDS. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS.
GT199800188A (en) PIPERIDINYLAMINOMETHYL TRIFLUOROMETHYL CYCLE ETHER COMPOUNDS AS ANTAGONISTS OF THE SUBSTANCE P.